Europe Metagenomics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Metagenomics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Metagenomics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Metagenomics Market Regional Analysis

6.2 Europe Metagenomics Market Revenue 2016-2027 (US$ Million)

6.3 Europe Metagenomics Market Forecast Analysis

7. Europe Metagenomics Market Analysis – by Product

7.1 Instruments & Software and Consumables

7.1.1 Overview
7.1.2 Instruments & Software and Consumables: Europe Metagenomics Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. Europe Metagenomics Market Analysis – by Application

8.1 Clinical Diagnostics

8.1.1 Overview
8.1.2 Clinical Diagnostics: Europe Metagenomics Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.2 Drug Discovery Metagenomics

8.2.1 Overview
8.2.2 Drug Discovery Metagenomics: Europe Metagenomics Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. Europe Metagenomics Market – Europe Analysis

9.1 Overview

9.2 Europe

9.2.1 Europe Metagenomics Market Breakdown, by Key Country, 2019 and 2027 (%)
9.2.1.1 Europe Metagenomics Market – Revenue and Forecast Analysis – by Country
9.2.1.1 UK: Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.1.1 UK: Europe Metagenomics Market Breakdown, by Product
9.2.1.1.2 UK: Europe Metagenomics Market Breakdown, by Application

9.2.1.2 Germany: Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.2.1 Germany: Europe Metagenomics Market Breakdown, by Product
9.2.1.2.2 Germany: Europe Metagenomics Market Breakdown, by Application

9.2.1.3 France: Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.3.1 France: Europe Metagenomics Market Breakdown, by Product
9.2.1.3.2 France: Europe Metagenomics Market Breakdown, by Application

9.2.1.4 Russia: Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.4.1 Russia: Europe Metagenomics Market Breakdown, by Product
9.2.1.4.2 Russia: Europe Metagenomics Market Breakdown, by Application

9.2.1.5 Italy: Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.5.1 Italy: Europe Metagenomics Market Breakdown, by Product
9.2.1.5.2 Italy: Europe Metagenomics Market Breakdown, by Application

9.2.1.6 Rest of Europe: Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.6.1 Rest of Europe: Europe Metagenomics Market Breakdown, by Product
9.2.1.6.2 Rest of Europe: Europe Metagenomics Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Merck KGaA

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Thermo Fisher Scientific Inc.

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Agilent Technologies

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Qiagen

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Bio-Rad Laboratories, Inc.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Perkinelmer Inc.

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Illumina Inc.

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 F Hoffman-La Roche Ltd.

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Oxford Nanopore Technologies Ltd.

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 Pacific Bioscience of California, Inc.

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Europe Metagenomics Market

Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country